Nano-Liposome Co-Loaded with C-X-C Chemokine Ligand 12/CXCR4 Pathway Inhibitor Synergistically Increases the Immune Efficacy of Anti-PD-L1 and Increase Anti-Tumor Activity of Effector T Cells

Source: Journal of Biomedical Nanotechnology - Category: Nanotechnology Authors: Tags: research-article Source Type: research
More News: Nanotechnology